ClearView Healthcare Partners competitors

Alan Garrett is a Chief Executive Officer at Carson Tahoe Health and Exec Dir:Finance at St. Joseph Hospital. He has worked as Trustee at St. Mary Medical Center, Executive VP/COO at St. Joseph Hospital, and Chief Financial Officer at St. Joseph Hospital.

Master's prepared and board certified healthcare executive with leadership roles at regional medical centers. Recognized for success in physician recruitment, expense management, and new business development. Established record of developing organization cultures with top percentile quality, productivity, and engagement.

Maria Ryan is a Chief Executive Officer at Cottage Hospital. She has worked as Chief Nursing Officer/COO at Cottage Hospital. Maria works or has worked as MEMBER at All Nippon Airways, MEMBER at New Hampshire Hospital Association, and MEMBER at International Nurses Association. She studied at Warren Pacific University.

Phil Mazzuca is responsible for overseeing all aspects of the company’s hospital operations and leads IASIS in its commitments to clinical excellence, developing an appropriate mix of quality services, physician relationships, effective staffing and supply utilization, payor contracts, and the management of capital investments related to operations. Mazzuca has more than 30 years of hospital and healthcare leadership experience, having previously served as president and chief executive officer of Brim Holdings, executive vice president and chief operating officer of MedCath Corporation, and president of the Texas and Florida markets for IASIS Healthcare.

Mike has more than 20 years of experience in the biotechnology industry, with the last 14 focused on creating and operating early stage therapeutic-focused companies. He was most recently Chief Operating Officer at Decibel Therapeutics, a biotechnology company focused on broadly treating hearing disorders. Mike’s involvement at Decibel was part of his work as an Entrepreneur-in-Residence at Third Rock Ventures; he led a team that created Decibel’s business plan resulting in a $52 M Series A round. Prior to Decibel, Mike was Chief Operating Officer at Ember Therapeutics, a Third Rock Ventures company focused on obesity and diabetes, and Chief Business Officer at Link Medicine, a neurodegeneration focused biotechnology company that was sold to Astra Zeneca. Mike was also a founder and VP of Discovery at Epizyme Therapeutics, a company focused on epigenetic modulators that is now a publicly traded company, and VP of Discovery at Hypnion, Inc a sleep disorder company that was sold to Lilly in 2007 for $325 million. Mike also spent two years as a biotechnology analyst at Bank of America Securities. He started his career at Millennium Pharmaceuticals, where he was project leader for multiple programs.